Nutraceutical Merchant Account: Payment Processing Guide

A nutraceutical merchant account has to underwrite around two separate risk factors most other ecommerce categories don't combine: what the business is legally allowed to claim about its products, and how it bills for them.

The two risk factors underwriters actually weigh#

The FDA permits structure/function statements for dietary supplements, things like "supports immune health," which 21 CFR 101.93(f) defines as statements describing the role of a nutrient or dietary ingredient in affecting the structure or function of the body. Disease treatment and cure claims are a different category and are not permitted. That notification duty is codified: no later than 30 days after first marketing a dietary supplement bearing such a statement, the manufacturer, packer, or distributor must notify the FDA's Office of Dietary Supplement Programs (21 CFR 101.93(a)(1)). Underwriters increasingly want that notification on file before approval. The FTC has brought repeated enforcement actions against supplement marketers for unsubstantiated efficacy claims. That's the regulatory side.

The billing side is where most of the chargeback volume actually comes from. A large share of nutra revenue runs through negative-option continuity programs: pay a small amount for a "free trial," then get billed automatically every month until canceling. The FTC has specifically scrutinized this model under its Negative Option Rule, and it reliably produces some of the highest chargeback ratios in ecommerce, because customers dispute the recurring charge instead of calling to cancel.

The scale of dietary supplement demand right now#

More than half of US adults, 60.2%, use at least one dietary supplement, according to the CDC's National Center for Health Statistics, with women reporting higher use (66.1%) than men (53.9%) (CDC/NCHS, 2024). That scale is exactly why acquiring banks keep underwriting nutra instead of declining it wholesale. It isn't a niche category. It's mainstream consumer spending with real repeat-purchase behavior already built in.

Demand at that scale is also what makes continuity billing so attractive to supplement brands in the first place. A customer who already reorders a multivitamin or protein powder every month is a good candidate for autoship, and autoship is genuinely convenient when it's disclosed clearly and cancellation is easy. The dispute problem isn't the subscription model itself. It's the subset of brands that bury the recurring-billing terms to juice trial conversion, then get hit with the chargebacks months later from customers who never really opted in.

That's also why underwriters don't treat "high supplement demand" and "high dispute risk" as contradictory signals. Both are true at once, and the account structure has to be built around that reality rather than pretending the volume isn't there.

How the account gets structured around both#

A nutraceutical and supplement merchant account gets placed with acquiring banks that have direct experience underwriting continuity and autoship billing models. That's different from a generic ecommerce account stretched to fit. Many acquirers prefer segmenting autoship continuity billing onto a separate MID from one-time checkout sales, and it's usually the right call. Continuity billing typically runs a higher dispute ratio, and keeping it separate protects the clean account's metrics. That structure is also what makes international growth possible later, using the same dual-MID logic behind any international merchant account setup: it's how one supplement brand we placed scaled into EU and US acquiring with zero downtime and settlement in 3 currencies.

Ethoca and Verifi alert integration lets a dispute get refunded before it's formally recorded against the ratio, and a gateway descriptor matching the product label, not a generic parent-company name, cuts down on the "unrecognized charge" disputes that drive so much of the category's volume.

Why the FTC's click-to-cancel rule collapsed, and why it still matters for autoship risk#

The FTC finalized an amended Negative Option Rule in October 2024, widely called "click-to-cancel," which required cancellation to be at least as easy as sign-up. In July 2025, the Eighth Circuit Court of Appeals vacated that amended rule on procedural grounds, ruling the FTC skipped a required preliminary regulatory analysis for a rule projected to affect the economy by more than $100 million a year (FTC, 2025).

That doesn't mean the underlying dispute risk went away. It means the enforcement mechanism shifted. The FTC's original 1973 Negative Option Rule and its general authority over unfair and deceptive practices both remain fully in force, several states run their own automatic-renewal disclosure laws that are stricter than anything federal, and card network dispute monitoring doesn't care what a federal rule's litigation status is. A brand that treats the vacatur as permission to loosen its cancellation flow is optimizing for a rule that could get replaced or re-litigated, while ignoring the chargeback consequence that still shows up in Visa's and Mastercard's monitoring programs no matter what happens in court.

The practical takeaway for a nutra brand: build the cancellation flow to the "as easy as sign-up" standard anyway. It was never really optional from a dispute-prevention standpoint, court ruling or not.

The Per-Cardholder Daily Cap Nobody Mentions#

One published Visa rule bears directly on autoship and almost never comes up.

An acquirer must ensure its card-absent merchant sets daily limits after which the merchant performs additional verification confirming the cardholder approves continued spend. Those limits must suit the business, but they must not exceed 25 transactions in one day (Visa Core Rules 10.4.4.2, 18 April 2026).

For most supplement brands that ceiling is irrelevant, since a customer buys once a month. It matters if you're running high-frequency retries against a failing card, which is a common and quietly damaging response to declined autoship charges. Repeated retries against one credential push toward that limit and read as exactly the pattern the rule exists to catch. Fixing the underlying decline with an account updater beats retrying.

What underwriters and the FTC both want to see#

Clear ingredient listing, the required FDA disclaimer that statements haven't been evaluated by the FDA, an explicit refund and cancellation policy, and, for any trial or autoship offer, a clear and unmissable disclosure of recurring billing terms before checkout. That last point does double duty: it's both an FTC compliance requirement and the single best lever for reducing dispute rates.

Choosing between one-time and continuity billing at launch#

A new supplement brand doesn't have to pick one model at underwriting and live with it. Most acquirers can structure an account for one-time sales first, then add a segmented continuity MID once the autoship program actually launches. Deciding this order upfront, rather than retrofitting it later, avoids a mid-relationship account restructure.